Keri concentrates her practice on complex patent cases for clients in the pharmaceutical and biotechnology industries. She is a registered patent attorney and represents companies in Hatch-Waxman and biosimilar litigation. Keri handles all aspects of patent cases including pre-suit investigations, fact and expert discovery, dispositive motions, and trials. She also has experience in IPR matters at the PTAB on behalf of both patent owners and challengers.
Prior to attending law school, Keri received her Ph.D. in immunology from Wayne State University School of Medicine where, as a part of her doctoral research, she studied human CD8+ T cell responses to HIV epitopes and mimotopes thereof. Keri then completed a postdoctoral fellowship at the University of Michigan where she examined the role of transforming growth factor-β (TGF-β) in natural killer (NK) cell maturation. Keri has been published in numerous immunology journals.
Keri is a graduate of Loyola University Chicago School of Law, and earned a bachelor’s degree in biology and anthropology from the University of Michigan.